Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Acta Neurochirurgica
Published in: Acta Neurochirurgica 11/2013

01-11-2013 | Clinical Article - Brain Injury

Somatotropic and thyroid hormones in the acute phase of subarachnoid haemorrhage

Authors: Maria Zetterling, Britt Edén Engström, Steinunn Arnardottir, Elisabeth Ronne-Engström

Published in: Acta Neurochirurgica | Issue 11/2013

Login to get access

Abstract

Background

Somatotropic and thyroid hormones are probably important for the recovery after acute brain injury. Still, the dynamics of these hormones after spontaneous subarachnoid haemorrhage (SAH) is not well described. The purpose of this study was to investigate the relation between somatotropic and thyroid hormones and clinical factors after SAH.

Methods

Twenty patients with spontaneous SAH were included prospectively. Serum concentrations of TSH, fT4, T3, IGF-1 and GH were measured once a day for 7 days after SAH. Hormone patterns and serum concentrations were compared to the severity of SAH, neurological condition at admission, clinical course and outcome of the patients.

Results

During the first week after SAH, all patients showed increased GH and IGF-1 concentrations. In the whole group, concentrations of TSH increased, whereas T3 and fT4 decreased. There were no relations of serum concentrations of IGF-1 or GH to clinical condition at admission, clinical course or outcome of the patients. Half of the patients showed low T3 serum concentrations. A complicated course was associated with a deeper fall in TSH and T3 concentrations. There were negative correlations for mean concentrations of TSH and T3 versus WFNS grade and a positive correlation for T3 versus GOS after 6 months, indicating that low concentrations of TSH and T3 were connected to worse SAH grade and poor outcome.

Conclusions

All patients showed increased GH and IGF-1 concentrations irrespective of the grade of SAH or clinical course. Patients with a complicated clinical course showed a more pronounced fall in TSH and T3 concentrations and low serum T3 concentrations were related to a more serious SAH and poor patient outcome. These results need to be studied further and they may contribute to the accumulated knowledge needed to understand the complex mechanisms influencing the unpredictable clinical course after SAH.
Literature
1.
Aleman A, Torres-Aleman I (2009) Circulating insulin-like growth factor I and cognitive function: neuromodulation throughout the lifespan. Prog Neurobiol 89:256–265PubMedCrossRef
2.
Ambrosius W, Kazmierski R, Gupta V, Warot AW, Adamczewska-Kocialkowska D, Blazejewska A, Ziemnicka K, Nowinski WL (2011) Low free triiodothyronine levels are related to poor prognosis in acute ischemic stroke. Exp Clin Endocrinol Diabetes 119:139–143PubMedCrossRef
3.
Baxter RC, Hawker FH, To C, Stewart PM, Holman SR (1998) Thirty-day monitoring of insulin-like growth factors and their binding proteins in intensive care unit patients. Growth Hormon IGF Res 8:455–463CrossRef
4.
Bendel S, Koivisto T, Ryynanen OP, Ruokonen E, Romppanen J, Kiviniemi V, Uusaro A (2010) Insulin like growth factor-I in acute subarachnoid hemorrhage: a prospective cohort study. Crit Care 14:R75PubMedCrossRef
5.
Bondanelli M, Ambrosio MR, Onofri A, Bergonzoni A, Lavezzi S, Zatelli MC, Valle D, Basaglia N, degli Uberti EC (2006) Predictive value of circulating insulin-like growth factor I levels in ischemic stroke outcome. J Clin Endocrinol Metab 91:3928–3934PubMedCrossRef
6.
Bondy CA, Cheng CM (2004) Signaling by insulin-like growth factor 1 in brain. Eur J Pharmacol 490:25–31PubMedCrossRef
7.
Chopra IJ, Huang TS, Beredo A, Solomon DH, Chua Teco GN, Mead JF (1985) Evidence for an inhibitor of extrathyroidal conversion of thyroxine to 3,5,3′-triiodothyronine in sera of patients with nonthyroidal illnesses. J Clin Endocrinol Metab 60:666–672PubMedCrossRef
8.
de Groof F, Joosten KF, Janssen JA, de Kleijn ED, Hazelzet JA, Hop WC, Uitterlinden P, van Doorn J, Hokken-Koelega AC (2002) Acute stress response in children with meningococcal sepsis: important differences in the growth hormone/insulin-like growth factor I axis between nonsurvivors and survivors. J Clin Endocrinol Metab 87:3118–3124PubMedCrossRef
9.
De Groot LJ (1999) Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metab 84:151–164PubMedCrossRef
10.
Denti L, Annoni V, Cattadori E, Salvagnini MA, Visioli S, Merli MF, Corradi F, Ceresini G, Valenti G, Hoffman AR, Ceda GP (2004) Insulin-like growth factor 1 as a predictor of ischemic stroke outcome in the elderly. Am J Med 117:312–317PubMedCrossRef
11.
Drake G (1988) Report of World Federation of Neurological Surgeons Committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg 68:985–086
12.
Elijah IE, Branski LK, Finnerty CC, Herndon DN (2011) The GH/IGF-1 system in critical illness. Best Pract Res Clin Endocrinol Metab 25:759–767PubMedCrossRef
13.
Fisher CM, Kistler JP, Davis JM (1980) Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6:1–9PubMedCrossRef
14.
Gehrmann J, Yao DL, Bonetti B, Bondy CA, Brenner M, Zhou J, Kreutzberg GW, Webster HD (1994) Expression of insulin-like growth factor-I and related peptides during motoneuron regeneration. Exp Neurol 128:202–210PubMedCrossRef
15.
Grote E, Hassler W (1988) The critical first minutes after subarachnoid hemorrhage. Neurosurgery 22:654–661PubMedCrossRef
16.
Harada N, Shimozawa N, Okajima K (2009) AT(1) receptor blockers increase insulin-like growth factor-I production by stimulating sensory neurons in spontaneously hypertensive rats. Transl Res 154:142–152PubMedCrossRef
17.
Harada N, Zhao J, Kurihara H, Nakagata N, Okajima K (2011) Desalted deep-sea water improves cognitive function in mice by increasing the production of insulin-like growth factor-I in the hippocampus. Transl Res 158:106–117PubMedCrossRef
18.
Hurcombe SD, Toribio RE, Slovis N, Kohn CW, Refsal K, Saville W, Mudge MC (2008) Blood arginine vasopressin, adrenocorticotropin hormone, and cortisol concentrations at admission in septic and critically ill foals and their association with survival. J Vet Intern Med 22:639–647PubMedCrossRef
19.
Jakubowski J (1995) Blood supply, blood flow and autoregulation in the adenohypophysis, and altered patterns in oestrogen-induced adenomatous hyperplasia. Br J Neurosurg 9:331–346PubMedCrossRef
20.
21.
Kaptein EM, Grieb DA, Spencer CA, Wheeler WS, Nicoloff JT (1981) Thyroxine metabolism in the low thyroxine state of critical nonthyroidal illnesses. J Clin Endocrinol Metab 53:764–771PubMedCrossRef
22.
Klose M, Brennum J, Poulsgaard L, Kosteljanetz M, Wagner A, Feldt-Rasmussen U (2010) Hypopituitarism is uncommon after aneurysmal subarachnoid haemorrhage. Clin Endocrinol (Oxf) 73:95–101
23.
Komoly S, Hudson LD, Webster HD, Bondy CA (1992) Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination. Proc Natl Acad Sci USA 89:1894–1898PubMedCrossRef
24.
Kooijman R, Sarre S, Michotte Y, De Keyser J (2009) Insulin-like growth factor I: a potential neuroprotective compound for the treatment of acute ischemic stroke? Stroke 40:e83–e88PubMedCrossRef
25.
Landin-Wilhelmsen K, Lundberg PA, Lappas G, Wilhelmsen L (2004) Insulin-like growth factor I levels in healthy adults. Horm Res 62(Suppl 1):8–16PubMedCrossRef
26.
Lee WH, Clemens JA, Bondy CA (1992) Insulin-like growth factors in the response to cerebral ischemia. Mol Cell Neurosci 3:36–43PubMedCrossRef
27.
Li XS, Williams M, Bartlett WP (1998) Induction of IGF-1 mRNA expression following traumatic injury to the postnatal brain. Brain Res Mol Brain Res 57:92–96PubMedCrossRef
28.
Lim CF, Docter R, Visser TJ, Krenning EP, Bernard B, van Toor H, de Jong M, Hennemann G (1993) Inhibition of thyroxine transport into cultured rat hepatocytes by serum of nonuremic critically ill patients: effects of bilirubin and nonesterified fatty acids. J Clin Endocrinol Metab 76:1165–1172PubMedCrossRef
29.
Mebis L, van den Berghe G (2009) The hypothalamus-pituitary-thyroid axis in critical illness. Neth J Med 67:332–340PubMed
30.
Mebis L, Van den Berghe G (2011) Thyroid axis function and dysfunction in critical illness. Best Pract Res Clin Endocrinol Metab 25:745–757PubMedCrossRef
31.
Mesotten D, Wouters PJ, Peeters RP, Hardman KV, Holly JM, Baxter RC, Van den Berghe G (2004) Regulation of the somatotropic axis by intensive insulin therapy during protracted critical illness. J Clin Endocrinol Metab 89:3105–3113PubMedCrossRef
32.
Okajima K, Harada N (2008) Promotion of insulin-like growth factor-I production by sensory neuron stimulation; molecular mechanism(s) and therapeutic implications. Curr Med Chem 15:3095–3112PubMedCrossRef
33.
Parenti G, Cecchi PC, Ragghianti B, Schwarz A, Ammannati F, Mennonna P, Di Rita A, Gallina P, Di Lorenzo N, Innocenti P, Forti G, Peri A (2011) Evaluation of the anterior pituitary function in the acute phase after spontaneous subarachnoid hemorrhage. J Endocrinol Investig 34:361–365
34.
Pritz MB, Giannotta SL, Kindt GW, McGillicuddy JE, Prager RL (1978) Treatment of patients with neurological deficits associated with cerebral vasospasm by intravascular volume expansion. Neurosurgery 3:364–368PubMedCrossRef
35.
Reinhardt RR, Bondy CA (1994) Insulin-like growth factors cross the blood–brain barrier. Endocrinology 135:1753–1761PubMedCrossRef
36.
Ross R, Miell J, Freeman E, Jones J, Matthews D, Preece M, Buchanan C (1991) Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I. Clin Endocrinol (Oxf) 35:47–54CrossRef
37.
Rothwell PM, Lawler PG (1995) Prediction of outcome in intensive care patients using endocrine parameters. Crit Care Med 23:78–83PubMedCrossRef
38.
Ryttlefors M, Howells T, Nilsson P, Ronne-Engstrom E, Enblad P (2007) Secondary insults in subarachnoid hemorrhage: occurrence and impact on outcome and clinical deterioration. Neurosurgery 61:704–714, discussion 714–705PubMedCrossRef
39.
Savaridas T, Andrews PJ, Harris B (2004) Cortisol dynamics following acute severe brain injury. Intensive Care Med 30:1479–1483PubMedCrossRef
40.
Tanriverdi F, Dagli AT, Karaca Z, Unluhizarci K, Selcuklu A, Casanueva FF, Kelestimur F (2007) High risk of pituitary dysfunction due to aneurysmal subarachnoid haemorrhage: a prospective investigation of anterior pituitary function in the acute phase and 12 months after the event. Clin Endocrinol (Oxf) 67:931–937CrossRef
41.
Teasdale G, Jennett B (1974) Assessment of coma and impaired consciousness. A practical scale. Lancet 2:81–84PubMedCrossRef
42.
Tenedieva ND, Tenedieva VD, Eliava S, Krymskii VA, Shakhnovich AR, Amcheslavskii VG, Toma GI, Dausheva AA, Mikrikova LV, Voronov VG (2002) [Cerebral low T3 syndrome]. Zh Vopr Neirokhir Im N N Burdenko:16–21; discussion 21
43.
Van den Berghe G (2000) Novel insights into the neuroendocrinology of critical illness. Eur J Endocrinol 143:1–13PubMedCrossRef
44.
Van den Berghe G, de Zegher F, Bouillon R (1998) Clinical review 95: acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 83:1827–1834PubMedCrossRef
45.
van Rijn MJ, Slooter AJ, Bos MJ, Catarino CF, Koudstaal PJ, Hofman A, Breteler MM, van Duijn CM (2006) Insulin-like growth factor I promoter polymorphism, risk of stroke, and survival after stroke: the Rotterdam study. J Neurol Neurosurg Psychiatry 77:24–27PubMedCrossRef
46.
Vermes I, Beishuizen A (2001) The hypothalamic-pituitary-adrenal response to critical illness. Best Pract Res Clin Endocrinol Metab 15:495–511PubMedCrossRef
47.
Zetterling M, Hillered L, Enblad P, Karlsson T, Ronne-Engstrom E (2011) Relation between brain interstitial and systemic glucose concentrations after subarachnoid hemorrhage. J Neurosurg 115:66–74PubMedCrossRef
48.
Zhang Y, Meyer MA (2010) Clinical analysis on alteration of thyroid hormones in the serum of patients with acute ischemic stroke. Stroke Res Treat 2010.pii:290678. doi:10.​4061/​2010/​290678
Metadata
Title
Somatotropic and thyroid hormones in the acute phase of subarachnoid haemorrhage
Authors
Maria Zetterling
Britt Edén Engström
Steinunn Arnardottir
Elisabeth Ronne-Engström
Publication date
01-11-2013
Publisher
Springer Vienna
Published in
Acta Neurochirurgica / Issue 11/2013
Print ISSN: 0001-6268
Electronic ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-013-1670-8

Other articles of this Issue 11/2013

Acta Neurochirurgica 11/2013 Go to the issue

Clinical Article - Vascular

Improved outcome of patients with severe thalamic hemorrhage treated with cerebrospinal fluid drainage and neurocritical care during 1990–1994 and 2005–2009

How I Do it - Neurosurgical Techniques

Microsurgical management of distal anterior cerebral artery aneurysms: from basic to complex, a video review of four cases

How I Do it - Vascular

How I Do it: side to side posterior inferior cerebellar artery –posterior inferior cerebellar artery bypass procedure

Clinical Article - Vascular

Current practice in neuropsychological outcome reporting after aneurysmal subarachnoid haemorrhage

Experimental research - Neurosurgical Anatomy

Falcine venous plexus within the falx cerebri: anatomical and scanning electron microscopic findings and clinical significance

Clinical Article - Brain Injury

Validation of a new neurological score (FOUR Score) in the assessment of neurosurgical patients with severely impaired consciousness